Literature DB >> 8631266

Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells.

Y I Yeom1, G Fuhrmann, C E Ovitt, A Brehm, K Ohbo, M Gross, K Hübner, H R Schöler.   

Abstract

The totipotent stem cells of the pregastrulation mouse embryo which give rise to all embryonic somatic tissues and germ cells express Oct-4. The expression is downregulated during gastrulation and is thereafter only maintained in the germline lineage. Oct-4/lacZ transgenes were used to determine how this pattern of expression was achieved, and resulted in the identification of two separate regulatory elements. The distal element drives Oct-4 expression in preimplantation embryos, in migratory and postmigratory primordial germ cells but is inactive in cells of the epiblast. In cell lines this element is specifically active in embryonic stem and embryonic germ cells. The proximal element directs the epiblast-specific expression pattern, including downregulation during gastrulation; in cell lines its activity is restricted to epiblast-derived cells. Thus, Oct-4 expression in the germline is regulated separately from epiblast expression. This provides the first marker for the identification of totipotent cells in the embryo, and suggests that expression of Oct-4 in the totipotent cycle is dependent on a set of factors unique to the germline.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631266     DOI: 10.1242/dev.122.3.881

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  303 in total

1.  Pre-selection of integration sites imparts repeatable transgene expression.

Authors:  H Wallace; R Ansell; J Clark; J McWhir
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.

Authors:  Hitoshi Niwa; Shinji Masui; Ian Chambers; Austin G Smith; Jun-ichi Miyazaki
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

Review 3.  From teratocarcinomas to embryonic stem cells.

Authors:  Peter W Andrews
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

4.  Isolation of undifferentiated and early differentiating type A spermatogonia from Pou5f1-GFP reporter mice.

Authors:  Thomas Garcia; Marie-Claude Hofmann
Journal:  Methods Mol Biol       Date:  2012

5.  Specification of germ cell fate in mice.

Authors:  Mitinori Saitou; Bernhard Payer; Ulrike C Lange; Sylvia Erhardt; Sheila C Barton; M Azim Surani
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-08-29       Impact factor: 6.237

6.  Neurogenin3 triggers beta-cell differentiation of retinoic acid-derived endoderm cells.

Authors:  Amedeo Vetere; Eleonora Marsich; Matteo Di Piazza; Raffaella Koncan; Fulvio Micali; Sergio Paoletti
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

7.  Crystal structure of a POU/HMG/DNA ternary complex suggests differential assembly of Oct4 and Sox2 on two enhancers.

Authors:  Attila Reményi; Katharina Lins; L Johan Nissen; Rolland Reinbold; Hans R Schöler; Matthias Wilmanns
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

8.  Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression.

Authors:  Takao Kuroda; Masako Tada; Hiroshi Kubota; Hironobu Kimura; Shin-ya Hatano; Hirofumi Suemori; Norio Nakatsuji; Takashi Tada
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Self-renewal and differentiation of mouse embryonic stem cells as measured by Oct4 expression: the role of the cAMP/PKA pathway.

Authors:  S Faherty; A Fitzgerald; M Keohan; L R Quinlan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-01       Impact factor: 2.416

10.  Pluripotency deficit in clones overcome by clone-clone aggregation: epigenetic complementation?

Authors:  Michele Boiani; Sigrid Eckardt; N Adrian Leu; Hans R Schöler; K John McLaughlin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.